RRAS2 and breast cancer: By comparing the parental CBM-MBC21 cell line and its RRAS2 knockdown derivative by Western blot analysis, we aimed to investigate if high R-RAS2 expression is needed in the murine BC cell line to sustain the activity of the three pathways when cells are cultured in full standard medium.